Detalhe da pesquisa
1.
Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases.
Mol Ther
; 32(3): 637-645, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204163
2.
pXST, a novel vector for TA cloning and blunt-end cloning.
BMC Biotechnol
; 18(1): 44, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005664